Abbott Laboratories buy Piper Jaffray Companies
Start price
19.09.24
/
50%
€103.70
Target price
19.09.25
€117.65
Performance (%)
12.09%
End price
20.09.25
€116.24
Summary
This prediction ended on 20.09.25 with a price of €116.24. The BUY prediction by Piper_Jaffray_Compan finished with a performance of 12.09%. A total of €1.08 was paid as dividends for this prediction. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -0.830% | -0.830% | -23.426% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten